Kidney Disease Drugs Market Report

China Kidney Disease Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Oct 12, 2023
  • PAGES：219
  • REPORT CODE：GMM1849334
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Kidney Disease Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer

    • Keryx Biopharmaceuticals

    • Changxing Pharmaceutical

    • zhejiang Shengbokang Pharmaceutical

    • AstraZeneca

    • Kissei Pharmaceutical

    • Amgen

    • Teva Pharmaceutical Industries

    • Sanofi

    • Hebei Ruisen Pharmaceutical

    • Roche

    • Datong Liqun Pharmaceutical

    • Tianjin Tongrentang Group

    By Type:

    • Capsule

    • Other

    • Tablets

    By Application:

    • Diabetic Nephropathy

    • Lupus Nephritis

    • Purpura Nephritis

    • Pediatric Kidney Disease

    • Renal Cyst (polycystic Kidney)

    • Chronic Renal Failure

    • Chronic Glomerulonephritis

    • Hypertensive Nephropathy

    • Kidney Stones

    • Nephrotic Syndrome

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Kidney Disease Drugs Market Overview 2018-2029

    • 1.1 China Kidney Disease Drugs Industry Development Overview

    • 1.2 China Kidney Disease Drugs Industry Development History

    • 1.3 China Kidney Disease Drugs Industry Market Size (2018-2029)

    • 1.4 China Kidney Disease Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Kidney Disease Drugs Production Volume, Production Value and Growth Rate of Capsule (2018-2029)

      • 1.4.2 China Kidney Disease Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.3 China Kidney Disease Drugs Production Volume, Production Value and Growth Rate of Tablets (2018-2029)

    • 1.5 China Kidney Disease Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Diabetic Nephropathy (2018-2029)

      • 1.5.2 China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Lupus Nephritis (2018-2029)

      • 1.5.3 China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Purpura Nephritis (2018-2029)

      • 1.5.4 China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Pediatric Kidney Disease (2018-2029)

      • 1.5.5 China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Renal Cyst (polycystic Kidney) (2018-2029)

      • 1.5.6 China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Chronic Renal Failure (2018-2029)

      • 1.5.7 China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Chronic Glomerulonephritis (2018-2029)

      • 1.5.8 China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Hypertensive Nephropathy (2018-2029)

      • 1.5.9 China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Kidney Stones (2018-2029)

      • 1.5.10 China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Nephrotic Syndrome (2018-2029)

    • 1.6 China Kidney Disease Drugs Market Analysis by Region

      • 1.6.1 North China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Kidney Disease Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Kidney Disease Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Kidney Disease Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Kidney Disease Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Kidney Disease Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Kidney Disease Drugs Industry Development

    Chapter 3 Kidney Disease DrugsIndustry Chain Analysis

    • 3.1 Kidney Disease Drugs Industry Chain

    • 3.2 Kidney Disease Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Kidney Disease Drugs Market

    • 3.3 Kidney Disease Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Kidney Disease Drugs Market

    Chapter 4 China Kidney Disease Drugs Market, by Type

    • 4.1 China Kidney Disease Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Kidney Disease Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Kidney Disease Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Kidney Disease Drugs Production Volume and Growth Rate of Capsule

      • 4.5.2 China Kidney Disease Drugs Production Volume and Growth Rate of Other

      • 4.5.3 China Kidney Disease Drugs Production Volume and Growth Rate of Tablets

    Chapter 5 China Kidney Disease Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Kidney Disease Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Kidney Disease Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Kidney Disease Drugs Market Size and Growth Rate of Diabetic Nephropathy

      • 5.5.2 China Kidney Disease Drugs Market Size and Growth Rate of Lupus Nephritis

      • 5.5.3 China Kidney Disease Drugs Market Size and Growth Rate of Purpura Nephritis

      • 5.5.4 China Kidney Disease Drugs Market Size and Growth Rate of Pediatric Kidney Disease

      • 5.5.5 China Kidney Disease Drugs Market Size and Growth Rate of Renal Cyst (polycystic Kidney)

      • 5.5.6 China Kidney Disease Drugs Market Size and Growth Rate of Chronic Renal Failure

      • 5.5.7 China Kidney Disease Drugs Market Size and Growth Rate of Chronic Glomerulonephritis

      • 5.5.8 China Kidney Disease Drugs Market Size and Growth Rate of Hypertensive Nephropathy

      • 5.5.9 China Kidney Disease Drugs Market Size and Growth Rate of Kidney Stones

      • 5.5.10 China Kidney Disease Drugs Market Size and Growth Rate of Nephrotic Syndrome

    Chapter 6 China Kidney Disease Drugs Market, by Region

    • 6.1 China Kidney Disease Drugs Production Volume and Production Value, by Region

    • 6.2 China Kidney Disease Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Kidney Disease Drugs Market Analysis

    • 7.1 North China Kidney Disease Drugs Market, by Type

    • 7.2 North China Kidney Disease Drugs Market, by Application

    Chapter 8 Central China Kidney Disease Drugs Market Analysis

    • 8.1 Central China Kidney Disease Drugs Market, by Type

    • 8.2 Central China Kidney Disease Drugs Market, by Application

    Chapter 9 South China Kidney Disease Drugs Market Analysis

    • 9.1 South China Kidney Disease Drugs Market, by Type

    • 9.2 South China Kidney Disease Drugs Market, by Application

    Chapter 10 East China Kidney Disease Drugs Market Analysis

    • 10.1 East China Kidney Disease Drugs Market, by Type

    • 10.2 East China Kidney Disease Drugs Market, by Application

    Chapter 11 Northeast China Kidney Disease Drugs Market Analysis

    • 11.1 Northeast China Kidney Disease Drugs Market, by Type

    • 11.2 Northeast China Kidney Disease Drugs Market, by Application

    Chapter 12 Southwest China Kidney Disease Drugs Market Analysis

    • 12.1 Southwest China Kidney Disease Drugs Market, by Type

    • 12.2 Southwest China Kidney Disease Drugs Market, by Application

    Chapter 13 Northwest China Kidney Disease Drugs Market Analysis

    • 13.1 Northwest China Kidney Disease Drugs Market, by Type

    • 13.2 Northwest China Kidney Disease Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer

        • 14.1.1 Pfizer Company Profile

        • 14.1.2 Pfizer Kidney Disease Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Keryx Biopharmaceuticals

        • 14.2.1 Keryx Biopharmaceuticals Company Profile

        • 14.2.2 Keryx Biopharmaceuticals Kidney Disease Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Changxing Pharmaceutical

        • 14.3.1 Changxing Pharmaceutical Company Profile

        • 14.3.2 Changxing Pharmaceutical Kidney Disease Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 zhejiang Shengbokang Pharmaceutical

        • 14.4.1 zhejiang Shengbokang Pharmaceutical Company Profile

        • 14.4.2 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 AstraZeneca

        • 14.5.1 AstraZeneca Company Profile

        • 14.5.2 AstraZeneca Kidney Disease Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Kissei Pharmaceutical

        • 14.6.1 Kissei Pharmaceutical Company Profile

        • 14.6.2 Kissei Pharmaceutical Kidney Disease Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Amgen

        • 14.7.1 Amgen Company Profile

        • 14.7.2 Amgen Kidney Disease Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Teva Pharmaceutical Industries

        • 14.8.1 Teva Pharmaceutical Industries Company Profile

        • 14.8.2 Teva Pharmaceutical Industries Kidney Disease Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Sanofi

        • 14.9.1 Sanofi Company Profile

        • 14.9.2 Sanofi Kidney Disease Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Hebei Ruisen Pharmaceutical

        • 14.10.1 Hebei Ruisen Pharmaceutical Company Profile

        • 14.10.2 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Roche

        • 14.11.1 Roche Company Profile

        • 14.11.2 Roche Kidney Disease Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Datong Liqun Pharmaceutical

        • 14.12.1 Datong Liqun Pharmaceutical Company Profile

        • 14.12.2 Datong Liqun Pharmaceutical Kidney Disease Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Tianjin Tongrentang Group

        • 14.13.1 Tianjin Tongrentang Group Company Profile

        • 14.13.2 Tianjin Tongrentang Group Kidney Disease Drugs Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Kidney Disease Drugs Industry Research Conclusions

    • 15.2 Kidney Disease Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Kidney Disease Drugs Industry Market Size (2018-2029)

    • Figure China Kidney Disease Drugs Production Volume, Production Value and Growth Rate of Capsule (2018-2029)

    • Figure China Kidney Disease Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Kidney Disease Drugs Production Volume, Production Value and Growth Rate of Tablets (2018-2029)

    • Figure China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Diabetic Nephropathy (2018-2029)

    • Figure China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Lupus Nephritis (2018-2029)

    • Figure China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Purpura Nephritis (2018-2029)

    • Figure China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Pediatric Kidney Disease (2018-2029)

    • Figure China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Renal Cyst (polycystic Kidney) (2018-2029)

    • Figure China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Chronic Renal Failure (2018-2029)

    • Figure China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Chronic Glomerulonephritis (2018-2029)

    • Figure China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Hypertensive Nephropathy (2018-2029)

    • Figure China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Kidney Stones (2018-2029)

    • Figure China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate of Nephrotic Syndrome (2018-2029)

    • Figure North China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Kidney Disease Drugs Market Size and Growth Rate from 2018-2029

    • Figure Kidney Disease Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Kidney Disease Drugs Market Share by Type in 2018

    • Figure China Kidney Disease Drugs Market Share by Type in 2023

    • Figure China Kidney Disease Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Kidney Disease Drugs Production Volume and Growth Rate of Capsule (2018-2023)

    • Figure China Kidney Disease Drugs Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Kidney Disease Drugs Production Volume and Growth Rate of Tablets (2018-2023)

    • Figure China Kidney Disease Drugs Market Share by Application in 2018

    • Figure China Kidney Disease Drugs Market Share by Application in 2023

    • Figure China Kidney Disease Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Kidney Disease Drugs Market Size and Growth Rate of Diabetic Nephropathy (2018-2023)

    • Figure China Kidney Disease Drugs Market Size and Growth Rate of Lupus Nephritis (2018-2023)

    • Figure China Kidney Disease Drugs Market Size and Growth Rate of Purpura Nephritis (2018-2023)

    • Figure China Kidney Disease Drugs Market Size and Growth Rate of Pediatric Kidney Disease (2018-2023)

    • Figure China Kidney Disease Drugs Market Size and Growth Rate of Renal Cyst (polycystic Kidney) (2018-2023)

    • Figure China Kidney Disease Drugs Market Size and Growth Rate of Chronic Renal Failure (2018-2023)

    • Figure China Kidney Disease Drugs Market Size and Growth Rate of Chronic Glomerulonephritis (2018-2023)

    • Figure China Kidney Disease Drugs Market Size and Growth Rate of Hypertensive Nephropathy (2018-2023)

    • Figure China Kidney Disease Drugs Market Size and Growth Rate of Kidney Stones (2018-2023)

    • Figure China Kidney Disease Drugs Market Size and Growth Rate of Nephrotic Syndrome (2018-2023)

    • Table China Kidney Disease Drugs Production Volume by Region (2018-2023)

    • Table China Kidney Disease Drugs Production Volume Share by Region (2018-2023)

    • Figure China Kidney Disease Drugs Production Volume Share by Region (2018-2023)

    • Table China Kidney Disease Drugs Production Value by Region (2018-2023)

    • Table China Kidney Disease Drugs Production Value Share by Region (2018-2023)

    • Figure China Kidney Disease Drugs Production Value Share by Region (2018-2023)

    • Table China Kidney Disease Drugs Sales Volume by Region (2018-2023)

    • Table China Kidney Disease Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Kidney Disease Drugs Sales Volume Share by Region (2018-2023)

    • Table China Kidney Disease Drugs Sales Value by Region (2018-2023)

    • Table China Kidney Disease Drugs Sales Value Share by Region (2018-2023)

    • Figure China Kidney Disease Drugs Sales Value Share by Region (2018-2023)

    • Table North China Kidney Disease Drugs Production Volume by Type (2018-2023)

    • Table North China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Table North China Kidney Disease Drugs Sales Volume by Application (2018-2023)

    • Table North China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Kidney Disease Drugs Production Volume by Type (2018-2023)

    • Table Central China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Kidney Disease Drugs Sales Volume by Application (2018-2023)

    • Table Central China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Kidney Disease Drugs Production Volume by Type (2018-2023)

    • Table South China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Table South China Kidney Disease Drugs Sales Volume by Application (2018-2023)

    • Table South China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Kidney Disease Drugs Production Volume by Type (2018-2023)

    • Table East China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Table East China Kidney Disease Drugs Sales Volume by Application (2018-2023)

    • Table East China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Kidney Disease Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Kidney Disease Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Kidney Disease Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Kidney Disease Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Kidney Disease Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Kidney Disease Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Kidney Disease Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Kidney Disease Drugs Sales Volume Share by Application (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table Keryx Biopharmaceuticals Company Profile

    • Table Keryx Biopharmaceuticals Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table Changxing Pharmaceutical Company Profile

    • Table Changxing Pharmaceutical Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table zhejiang Shengbokang Pharmaceutical Company Profile

    • Table zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table Kissei Pharmaceutical Company Profile

    • Table Kissei Pharmaceutical Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Industries Company Profile

    • Table Teva Pharmaceutical Industries Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table Hebei Ruisen Pharmaceutical Company Profile

    • Table Hebei Ruisen Pharmaceutical Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table Datong Liqun Pharmaceutical Company Profile

    • Table Datong Liqun Pharmaceutical Kidney Disease Drugs Revenue, Price and Gross (2018-2023)

    • Table Tianjin Tongrentang Group Company Profile

    • Table Tianjin Tongrentang Group Kidney Disease Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US